Effects of exercise on VLDL-triglyceride oxidation and turnover.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3279302)

Published in Am J Physiol Endocrinol Metab on March 08, 2011

Authors

Esben Sondergaard1, Iben Rahbek, Lars P Sørensen, Jens S Christiansen, Lars C Gormsen, Michael D Jensen, Søren Nielsen

Author Affiliations

1: Dept. of Endocrinology and Internal Medicine, Aarhus Univ. Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark.

Articles cited by this

Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med (2002) 7.34

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes (1993) 1.78

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75

VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab (2009) 1.54

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care (2002) 1.53

Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. Clin Nutr (2004) 1.49

Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr (2003) 1.48

A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol (1995) 1.47

Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am J Physiol Endocrinol Metab (2005) 1.34

VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab (2002) 1.15

Free fatty acid turnover measured using ultralow doses of [U-13C]palmitate. J Lipid Res (1997) 1.10

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes (2010) 1.07

Fat utilization during exercise: adaptation to a fat-rich diet increases utilization of plasma fatty acids and very low density lipoprotein-triacylglycerol in humans. J Physiol (2001) 1.06

Carbohydrate loading and metabolism during exercise in men and women. J Appl Physiol (1985) (1995) 1.03

How valid are isotopic measurements of fatty acid oxidation? Am J Physiol (1991) 1.02

Acute exercise-induced changes in basal VLDL-triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance than endurance exercise. J Appl Physiol (1985) (2008) 0.97

Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta Med Scand (1971) 0.95

Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res (2005) 0.95

Effect of a marathon run on serum lipoproteins, creatine kinase, and lactate dehydrogenase in recreational runners. Res Q Exerc Sport (2005) 0.95

Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res (2006) 0.93

Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab (2008) 0.93

A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. J Lipid Res (1999) 0.91

A single bout of whole-body resistance exercise augments basal VLDL-triacylglycerol removal from plasma in healthy untrained men. Clin Sci (Lond) (2009) 0.90

Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon. Metabolism (1989) 0.90

Increased removal rate of exogenous triglycerides after prolonged exercise in man: time course and effect of exercise duration. Metabolism (1987) 0.89

Acute effects of prolonged exercise on serum lipids. Metabolism (1980) 0.89

The use of the [1,2-13C]acetate recovery factor in metabolic research. Eur J Appl Physiol (2003) 0.85

Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes (2002) 0.85

Increased VLDL-TAG turnover during and after acute moderate-intensity exercise. Med Sci Sports Exerc (2004) 0.82

Plasma lipid and lipoprotein responses during exercise. Scand J Clin Lab Invest (2003) 0.77

Articles by these authors

Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91

DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet (2006) 6.50

Interindividual variation in posture allocation: possible role in human obesity. Science (2005) 6.26

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol (2013) 5.24

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02

Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet (2002) 3.90

Aquaporin water channels--from atomic structure to clinical medicine. J Physiol (2002) 3.70

Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry (2011) 3.57

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA (2013) 3.49

Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34

Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab (2006) 3.03

Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71

Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53

Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38

Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23

Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol (2002) 2.23

Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A (2010) 2.17

Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am J Physiol Renal Physiol (2006) 2.17

Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16

Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice. Proc Natl Acad Sci U S A (2002) 1.97

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res (2003) 1.92

Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 1.88

Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr (2008) 1.80

Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care (2003) 1.78

Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A (2007) 1.76

Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2011) 1.67

Acute regulation of aquaporin-2 phosphorylation at Ser-264 by vasopressin. Proc Natl Acad Sci U S A (2008) 1.66

A current view of the mammalian aquaglyceroporins. Annu Rev Physiol (2008) 1.64

A Role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. Traffic (2006) 1.62

Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 1.62

A quick, reliable, and automated method for fat cell sizing. J Lipid Res (2003) 1.61

Immunocytochemical localization of pendrin in intercalated cell subtypes in rat and mouse kidney. Am J Physiol Renal Physiol (2002) 1.59

Muscle strength in type 2 diabetes. Diabetes (2004) 1.56

VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab (2009) 1.54

Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. Am J Physiol Regul Integr Comp Physiol (2007) 1.53

Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes (2011) 1.53

The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52

Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A (2006) 1.52

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes (2009) 1.51

Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res (2010) 1.50

Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Virol (2008) 1.48

ATP7B copper-regulated traffic and association with the tight junctions: copper excretion into the bile. Gastroenterology (2008) 1.48

Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res (2006) 1.48

Acute changes in lipoprotein subclasses during exercise. Metabolism (2013) 1.45

Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin Cancer Res (2004) 1.44

Functional requirement of aquaporin-5 in plasma membranes of sweat glands. Proc Natl Acad Sci U S A (2002) 1.41

Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans. J Physiol (2009) 1.41

Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology (2006) 1.39

Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res (2005) 1.38

Ion transporters in secretory and cyclically modulating ameloblasts: a new hypothesis for cellular control of preeruptive enamel maturation. Am J Physiol Cell Physiol (2010) 1.37

Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) (2010) 1.37

Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol (2006) 1.36

Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol (2004) 1.35

Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab (2008) 1.35

Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol (2006) 1.33

Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci U S A (2008) 1.33

The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol (2012) 1.32

Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab (2010) 1.31

Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab (2007) 1.31

Fat depots, free fatty acids, and dyslipidemia. Nutrients (2013) 1.30

Antioxidant supplementation does not alter endurance training adaptation. Med Sci Sports Exerc (2010) 1.30

Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol (2003) 1.26

Insulin dose response analysis of free fatty acid kinetics. Metabolism (2007) 1.26

Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab (2006) 1.25

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol (2004) 1.24

Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J (2008) 1.24

Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab (2007) 1.24

Preventing overestimation of pixels in computed tomography assessment of visceral fat. Obes Res (2004) 1.22

Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes (2008) 1.22

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20

Strength training and adiposity in premenopausal women: strong, healthy, and empowered study. Am J Clin Nutr (2007) 1.20

Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care (2007) 1.20

Meal fatty acid uptake in visceral fat in women. Diabetes (2007) 1.20

Leptin upregulates caveolin-1 expression: implications for development of atherosclerosis. Atherosclerosis (2010) 1.19

Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats. Am J Physiol Renal Physiol (2004) 1.19

Aquaporin-11: a channel protein lacking apparent transport function expressed in brain. BMC Biochem (2006) 1.19

Aquaporin 9 is the major pathway for glycerol uptake by mouse erythrocytes, with implications for malarial virulence. Proc Natl Acad Sci U S A (2007) 1.18

Axial heterogeneity in basolateral AQP2 localization in rat kidney: effect of vasopressin. Am J Physiol Renal Physiol (2002) 1.17

Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol (2004) 1.16

Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol (2004) 1.15

Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care (2005) 1.15

Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains. Breast Cancer Res Treat (2011) 1.13

Single-gene detection and karyotyping using small-target fluorescence in situ hybridization on maize somatic chromosomes. Genetics (2007) 1.13

Identification of AQP5 in lipid rafts and its translocation to apical membranes by activation of M3 mAChRs in interlobular ducts of rat parotid gland. Am J Physiol Cell Physiol (2005) 1.13

Basolateral Na+-dependent HCO3- transporter NBCn1-mediated HCO3- influx in rat medullary thick ascending limb. J Physiol (2003) 1.13

Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc Natl Acad Sci U S A (2002) 1.13

The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am J Clin Nutr (2008) 1.13

Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) (2009) 1.12

Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol (2003) 1.12

Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats. Am J Physiol Renal Physiol (2002) 1.10

A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom (2012) 1.10

AE4 is a DIDS-sensitive Cl(-)/HCO(-)(3) exchanger in the basolateral membrane of the renal CCD and the SMG duct. Am J Physiol Cell Physiol (2002) 1.10

Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol Endocrinol Metab (2007) 1.10